QuickView for transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. Whole blood of patients with single and double primary tumors and healthy controls
3. L1000 CMAP - Breast cancer MCF7.101 cells with CRISPR targeted gene knockouts
4. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
5. L1000 CMAP - Kidney epithelial HA1E.101 cells with CRISPR targeted gene knockouts

There were no matches for transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery

There were no clinical trials for transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery